LSEG:LSELondon Stock Exchange Group plc Analysis
Data as of 2026-05-20 - not real-time
£9,372.00
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
LSEG delivered record Q1 revenue up 9.8% beating consensus, driven by double‑digit growth in Markets and Risk Intelligence segments. Price sits at 9,372 £, well above the 20‑day SMA (9,462) and 50‑day SMA (9,089) but still below the 200‑day SMA (8,836), indicating a bullish short‑term trend despite a bearish MACD histogram (‑33.9) and a neutral RSI (52.6).
Valuation metrics show the stock trades at a trailing P/E of 39.5× versus an industry average of 16.7×, placing it in the overvalued tier, while the forward P/E of 17.5× suggests expected earnings acceleration. The upside/downside indicator of +31.7 % further underscores market optimism, yet the fear‑greed index at 90.3 (Extreme Greed) flags potential sentiment‑driven volatility.
Risk factors are mixed: 30‑day volatility of 25 % is high, beta is effectively neutral (‑0.04) limiting systematic market risk, and the financial‑services sector carries medium‑to‑high regulatory exposure. Liquidity appears solid with stable volume and a market cap of £45.96 bn, while dividend yield of 1.59 % and a payout ratio of 57 % are supported by robust operating cash flow (£3.62 bn) and free cash flow (£2.05 bn).
Overall, the combination of strong cash generation, record‑breaking revenue growth, and a sizable upside potential makes the stock attractive for investors with a short‑to‑medium horizon, but the elevated valuation and sector‑specific regulatory risk counsel caution for long‑term holders.
Valuation metrics show the stock trades at a trailing P/E of 39.5× versus an industry average of 16.7×, placing it in the overvalued tier, while the forward P/E of 17.5× suggests expected earnings acceleration. The upside/downside indicator of +31.7 % further underscores market optimism, yet the fear‑greed index at 90.3 (Extreme Greed) flags potential sentiment‑driven volatility.
Risk factors are mixed: 30‑day volatility of 25 % is high, beta is effectively neutral (‑0.04) limiting systematic market risk, and the financial‑services sector carries medium‑to‑high regulatory exposure. Liquidity appears solid with stable volume and a market cap of £45.96 bn, while dividend yield of 1.59 % and a payout ratio of 57 % are supported by robust operating cash flow (£3.62 bn) and free cash flow (£2.05 bn).
Overall, the combination of strong cash generation, record‑breaking revenue growth, and a sizable upside potential makes the stock attractive for investors with a short‑to‑medium horizon, but the elevated valuation and sector‑specific regulatory risk counsel caution for long‑term holders.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 8/10
Key Factors
- record Q1 revenue growth
- price above SMA20 and bullish short‑term trend
- MACD bearish histogram suggests near‑term pullback opportunity
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- forward P/E compression to 17.5×
- double‑digit segment growth expected to continue
- stable dividend yield and strong cash generation
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- trailing P/E of 39.5× versus industry average of 16.7×
- high regulatory exposure in financial‑services sector
- valuation compression risk may limit upside over time
Key Metrics & Analysis
Financial Health
Revenue Growth4.60%
Profit Margin13.36%
P/E Ratio39.5
ROE6.37%
ROA0.19%
Debt/Equity52.97
P/B Ratio2.4
Op. Cash Flow£3.6B
Free Cash Flow£2.1B
Industry P/E16.7
Technical Analysis
TrendBullish
RSI52.6
Support£8,196.00
Resistance£10,140.00
MA 20£9,462.80
MA 50£9,088.12
MA 200£8,835.69
MACDBearish
VolumeStable
Fear & Greed Index90.3
Valuation
Fair Value£5,039.10
Target Price£12,346.35
Upside/Downside31.74%
GradeOvervalued
TypeBlend
Dividend Yield1.59%
Risk Assessment
Beta-0.04
Volatility25.15%
Sector RiskHigh
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.